Researchers in Japan have developed a predictive model that could improve treatment decisions for advanced pancreatic cancer ...

The new technique is now the 'prime candidate' for potential clinical trials, raising hopes that for the first time, a ...

The new technique is now the 'prime candidate' for potential clinical trials, raising hopes that for the first time, a ...

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent MELBOURNE, Australia, April 29, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: ...

New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agentMELBOURNE, Australia, April ...

It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...

Targeted screening to participants in ≥90th percentile of polygenic risk score results in detection of cancer warranting clinical management in 55.1 percent.

Historically, small molecule drugs have been precisely designed down to the atomic scale. Considering their relatively large complex structures, nanomedicines have lagged behind. Researchers argue ...

IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced the presentation of new ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

In Anchorage, Providence Alaska Medical Center has become the first facility in the state to offer an innovative treatment ...